Ownership history in UBS Group AG · 6 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in PROTAGENIC THERAPEUTICS INC (PTIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 56 | -8,964 | -99.4% | 0.00% | $192 | $3.43 |
| 2025 Q2 | REDUCED | 9,020 | -5,394 | -37.4% | 0.00% | $33K | $3.65 |
| 2024 Q4 | ADDED | 14,414 | +4,674 | +48.0% | 0.00% | $7K | $6.86 |
| 2024 Q3 | REDUCED | 9,740 | -338 | -3.4% | 0.00% | $6K | $8.78 |
| 2024 Q2 | ADDED | 10,078 | +9,773 | +3204.3% | 0.00% | $9K | $12.67 |
| 2023 Q1 | INITIATED | 305 | — | — | 0.00% | $528 | $24.22 |
As of 2025 Q4 — sorted by position size